Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-033-5 | CAS number: 25068-38-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- mouse lymphoma assay using L5178Y cell line as described by Clive et al., 1979.
Clive, D., Johnson, K.O., Spector, J.F.S., Batson, A.G. and Brown, M.M.M. (1979). Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. Mutat. Res 59:61-108 - GLP compliance:
- no
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane
- EC Number:
- 500-033-5
- EC Name:
- 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane
- Cas Number:
- 25068-38-6
- Molecular formula:
- (C15H16O2 . C3H5ClO)x
- IUPAC Name:
- 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane
- Test material form:
- liquid: viscous
- Details on test material:
- EPON 828 (25068-38-6)
Constituent 1
Method
- Target gene:
- thymidine kinase gene (TK+/-)
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- The S-9 fraction was obtained from the livers of male Sprague-Dawley rats that were dosed with 500 mg/kg body weight of Aroclor 1254 and killed five days later.
- Test concentrations with justification for top dose:
- 0.0018-0.013 mg/mL nonactivated; 0.032-2.4 mg/L activated
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- no
- Remarks:
- Ethylmethane sulfonate without S9 and Benzo(a)pyrene with S9
- Positive control substance:
- other: Ethylmethane sulfonate without S9 and Benzo(a)pyrene with S9
- Details on test system and experimental conditions:
- Cells were treated with various test material concentrations, a negative control (vehicle) and a positive control (Ethylmethane sulfonate) concurrently for toxicity and mutagenicity.
Cells were counted on test day 2 for colony density. Cultures were selected for cloning for treated and both control groups, plated, and cultured for 10 days to determine viability. Mutant counts were recorded, and tutant frequency was calculated.
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- toxicity was noted in suspension growth at 0.18 mg/ml and higher
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Chemical analyses were performed on samples of EPON 828 used to dose the cells. The nominal concentration of both solutions was 100 mg/ml and the actual amount, as determined by analysis, was 104 +/- 1 mg/ml for Assay II (without S9) and 103 +/- mg/ml for Assay III (with S9). No anal;ysis was done on samples from Assay I as this was used as a preliminary assay to determine toxicity and establish dose levels for the mutagenicity assays (II and III).
In the absence of S-9 and EPON 828, there was a toxic effect on both suspension growth and soft agar growth and an increase in the mutant frequency at concentrations of 0.003 mg/ml and higher. The assay was repeated (Assay II) with 0.0075 mg/ml as the highest concentration and an additional five concentrations in decreasing 1/8 log10 dilutions. The results were similar to those obtained in the preliminary assay. There was evidence of a toxic effect on suspension growth and on soft agar growth commencing at 0.0024 mg/ml and a dose-related increase in mutants at all concentrations in the absense of S-9.
When EPON 828 was exposed to the cells in the presence of metabolic activation, no toxicity was noted on suspension growth or soft agar growth in Assay I at concentrations up to 0.1 mg/ml and there was no increase in the mutant frequency at any concentrations. Therefore in the repeat assay (III) a higher concentration, 0.24 mg/ml, was used and the other doses were set at 1/8 log 10 dilutions therefrom. Toxicity was apparent in suspension growth at 0.18 mg/ml and higher and in soft agar growth at 0.24 mg/ml. No increase in mutant frequency which exceeded 2-fold the background was noted at any concentration tested in the presence of S-9 metabolic activation. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Chemical analyses were performed on samples of EPON 828 used to dose the cells. The nominal concentration of both solutions was 100 mg/ml and the actual amount, as determined by analysis, was 104 +/- 1 mg/ml for Assay II (without S9) and 103 +/- mg/ml for Assay III (with S9). No anal;ysis was done on samples from Assay I as this was used as a preliminary assay to determine toxicity and establish dose levels for the mutagenicity assays (II and III).
In the absence of S-9 and EPON 828, there was a toxic effect on both suspension growth and soft agar growth and an increase in the mutant frequency at concentrations of 0.003 mg/ml and higher. The assay was repeated (Assay II) with 0.0075 mg/ml as the highest concentration and an additional five concentrations in decreasing 1/8 log10 dilutions. The results were similar to those obtained in the preliminary assay. There was evidence of a toxic effect on suspension growth and on soft agar growth commencing at 0.0024 mg/ml and a dose-related increase in mutants at all concentrations in the absense of S-9.
When EPON 828 was exposed to the cells in the presence of metabolic activation, no toxicity was noted on suspension growth or soft agar growth in Assay I at concentrations up to 0.1 mg/ml and there was no increase in the mutant frequency at any concentrations. Therefore in the repeat assay (III) a higher concentration, 0.24 mg/ml, was used and the other doses were set at 1/8 log 10 dilutions therefrom. Toxicity was apparent in suspension growth at 0.18 mg/ml and higher and in soft agar growth at 0.24 mg/ml. No increase in mutant frequency which exceeded 2-fold the background was noted at any concentration tested in the presence of S-9 metabolic activation.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
positive
EPON 828 was a direct acting mutagen in the mouse lymphoma gene mutation assay and such activity was eliminated by the addition of a metabolizing enzyme fraction derived from rat liver. - Executive summary:
EPON 828 was tested in the mouse lymphoma cell mutagenicity assay for its ability to induce gene mutation at the thymidine kinae locus in the absence and presence of activation by a rat liver microsome (S-9) fraction. Cells were exposed to concentrations of EPON 828 up to and including those which resulted in toxicity to the cells.
In the absence of activation, EPON 828 in DMSO produced a dose-related cytotoxic effect at concentrations of 0.0024 mg/ml and higher and a dose-related increase in the mutant frequency at concentrations from 0.0018 to 0.0056 mg/ml. The positive control (EMS, 0.8 mg/ml) produced a mutant frequency approximately 20 times that of the untreated control. In the presence of activation EPON 828 produced cytotoxic effects at concentrations of 0.18 mg/ml and higher; however, there was no increase in mutant frequency at any concentration tested. The positive control (P[a]P, 0.005 mg/ml) produced mutant frequency values greater than twofold that of the untreated control.
It can be concluded that APON 828 is a direct acting mutagen in the mouse lymphoma gene mutation assay and that this activity is removed by the addition of a rat liver metabolizing enzyme fraction.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.